Bioadaptives Inc - SIC # 5499 - MISCELLANEOUS FOOD STORES

Ticker Exchange SIC # Website Latest Ticker
BDPT Over the counter 5499 https://www.shopbioadaptives.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bioadaptives Inc

BioAdaptives, Inc. Establishes a Wholesale Division to Expand Marketing Presence in a USD 151.9 Billion Global Dietary Supplement Market - Dec 8th, 2022 1:00 pm
BioAdaptives, Inc. Introduces PROTEINnMORE, an Advanced, Plant-Based Lean Muscle Supplement for Fitness and Athletic Peak Performance - Dec 1st, 2022 1:00 pm
As Global Anti-aging Product Annual Sales are Expected to Exceed 44 Billion by 2027, BioAdaptives, Inc. Launches Cell Rejuven, an Advanced, Plant-Based Anti-Aging Supplement With Rejuvenating Effects - Nov 17th, 2022 1:00 pm
BioAdaptives Launches MindnMemory Nootropic Mental Focus, Clarity, Concentration - Jul 28th, 2022 11:00 am
BioAdaptives, Inc. Launching Next Generation Products for Natural Health Practitioners - Jul 14th, 2022 11:00 am
BioAdaptives, Inc. Introduces PrimiSleep™, An Advanced Sleep-Aid Designed to Harmonize with the Body's Unique Circadian Rhythm, Delivering Gentle, Sustained, Restorative Sleep With No "Hangover" - Jul 7th, 2022 11:00 am
BioAdaptives, Inc. Brings Top Revolutionary Formulas Together in Wellness Introductory Offer - Jun 29th, 2022 11:00 am
BioAdaptives, Inc. Seeks to Increase Market Share in $1.9 Billion Global Pet Supplements Market With Canine All-In-One Premium Nutraceutical - Jun 23rd, 2022 11:00 am
BioAdaptives, Inc. Reveals Corporate Strategy for a Strengthened Market Presence, Through Empowerment of Seniors, as Nutraceutical Market Surpasses $454 Billion USD - Jun 9th, 2022 11:00 am
BioAdaptives Sponsors COVID-19 Long Hauler Survey - Jun 2nd, 2022 11:00 am
BioAdaptives Expands Gadolinium Deposition Disease Survey - Feb 25th, 2022 3:00 pm
BioAdaptives Announces Initial Investigation Results Pluripain® Improves Symptoms of Gadolinium Deposition Disease - Feb 24th, 2022 12:00 pm
BioAdaptives Acquires Oxygenated Water Technology Patent and Forms Subsidiary, MORO2, Inc., to Create New Products - Feb 3rd, 2022 12:00 pm